Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2026)

Fulgent Genetics has disclosed Non-Current Debt across 6 years of filings, most recently posting $1.5 million for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $1.5 million, down 24.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 24.62% YoY), and the FY2025 annual result was $2.0 million, down 21.46% from the prior year.
• Non-Current Debt came in at $1.5 million for Q1 2026 at Fulgent Genetics, down from $2.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $3.4 million in Q4 2022 to a low of $1.5 million in Q1 2026.
• The 5-year median for Non-Current Debt is $2.5 million (2024), against an average of $2.3 million.
• Across the five-year window, Non-Current Debt declined 12.1% in 2023 and retreated 24.62% in 2026, its largest moves.
• Fulgent Genetics' Non-Current Debt stood at $3.4 million in 2022, then slipped by 12.1% to $3.0 million in 2023, then decreased by 15.89% to $2.5 million in 2024, then decreased by 21.46% to $2.0 million in 2025, then declined by 24.62% to $1.5 million in 2026.
• The last three Non-Current Debt figures came in at $1.5 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.